Los Angeles Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Los Angeles Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,572	Closed	-$323K	–	1693
2021 Q1	$323K	Sell	1,572 -43	-3%	-$9.4K	﹤0.01%	1410
2020 Q4	$323K	Sell	1,615 -1	-0.1%	-$208	﹤0.01%	1348
2020 Q3	$268K	Buy	1,616 +36	+2%	+$8.2K	﹤0.01%	1302
2020 Q2	$392K	Buy	1,580 +812	+106%	+$190K	﹤0.01%	1203
2020 Q1	$140K	Buy	+768	New	+$194K	﹤0.01%	1254
2019 Q3	–	Sell	-618	Closed	-$232K	–	1384
2019 Q2	$232K	Hold	618	–	–	﹤0.01%	1259
2019 Q1	$166K	Hold	618	–	–	﹤0.01%	1324
2018 Q4	$132K	Sell	618 -479	-44%	-$149K	﹤0.01%	1230
2018 Q3	$491K	Sell	1,097 -167	-13%	-$72.6K	﹤0.01%	1105
2018 Q2	$513K	Buy	+1,264	New	+$601K	﹤0.01%	1128

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Los Angeles Capital Management's PVLA Position: Q2 2021 in Review

Los Angeles Capital Management sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 1,572 shares — an estimated $323K sold.

Los Angeles Capital Management first reported a position in PVLA in Q2 2018 and held it in 10 quarters. The position peaked at $513K in Q2 2018. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

Los Angeles Capital Management reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
Los Angeles Capital Management sold 1,572 Palvella Therapeutics shares in Q2 2021, an estimated $323K.
Los Angeles Capital Management first reported a position in Palvella Therapeutics in Q2 2018 and held it in 10 quarters.
Los Angeles Capital Management's Palvella Therapeutics position peaked at $513K in Q2 2018.
73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.